FDC has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19 in the country. This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India. Convenient loading dosage of the oral suspension helps reduce dosage frequency.
FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).